Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1999
06/08/1999US5910451 Trophinin and trophinin-assisting proteins
06/08/1999US5910442 Nucleic acid coding for substrate of protein kinase c inserting it into a expression vector; transforming a host; anticarcinogenic agents
06/08/1999US5910441 DNA encoding fibronectin and fibrinogen binding protein from group A streptococci
06/08/1999US5910437 Ligated d-protein of formula r-l-r' where r and r' are peptides and l is linking group of thiol ester or selenol ester; for production of chirally pure chemicals and drugs; production of racemic crystals; prolonged half-life in body
06/08/1999US5910436 Trehalose phosphorylase, its preparation and uses
06/08/1999US5910431 Polynucleotides encoding chemokine α-2
06/08/1999US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50)
06/08/1999US5910427 Protein derivatives formed by replacement, substitution, or chemical modification of amino acids 57 and/or 60 having increased activity; for immunosuppressives/allergy treatments
06/08/1999US5910416 Adrenomedullin
06/08/1999US5910414 Diagnosing bacterial infection by screening infected tissue using probes to identify nucleic acid sequences og bacterial enzyme
06/08/1999US5910408 Screening population of nucleic acid molecules each with region of random sequence by incubating with substrate and complementary template nucleic acids, isolating active nucleic acids, then amplifying, optionally repeating
06/08/1999US5910404 Amino acid sequence of peptide mimetic; for screening blood and blood products; use as immunogens
06/08/1999US5910309 UV-induced factor for immunosuppression
06/08/1999US5910304 Oral administration in unit dosage, regulation of appetites and efficiency of food utilization, treatment of bovine respiratory disease complex
06/08/1999US5910303 Agent for promoting the platelet and the leukocyte productions
06/08/1999CA2242308A1 Novel compounds
06/08/1999CA2089972C Sulfonamidocarboxamides
06/08/1999CA1340588C Amino acid derivatives
06/08/1999CA1340587C Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates
06/03/1999WO1999027167A1 Process for the production of protein fibres and products thereof
06/03/1999WO1999027138A1 Nucleic acid ligands of tissue target
06/03/1999WO1999027134A1 Antisense oligonucleotide modulation of human serine/threonine protein phosphatase gene expression
06/03/1999WO1999027128A1 ribH
06/03/1999WO1999027127A1 NOVEL ribB
06/03/1999WO1999027126A1 ribG
06/03/1999WO1999027125A1 ribA
06/03/1999WO1999027122A1 Vectors inhibiting or delaying the binding of an immunodeficiency virus to cells
06/03/1999WO1999027112A1 Human irak-2, a human interleukin-1 receptor associated kinase-2
06/03/1999WO1999027111A1 Desaturase genes and their use
06/03/1999WO1999027109A2 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS)
06/03/1999WO1999027106A1 NOVEL guaA
06/03/1999WO1999027104A1 Histamine and serotonin binding molecules
06/03/1999WO1999027103A1 Mammalian cytokine-like polypeptide-10
06/03/1999WO1999027099A1 Orf, a substrate for extracellular signal-regulated kinase, erk-6, and related methods
06/03/1999WO1999027098A2 A-33 related antigens and their pharmacological uses
06/03/1999WO1999027097A2 CLONING OF A TETRODOTOXIN-RESISTANT SODIUM CHANNEL α-SUBUNIT
06/03/1999WO1999027096A1 A NOVEL EGF MOTIF PROTEIN OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN
06/03/1999WO1999027095A1 Human cdc10 homolog
06/03/1999WO1999027094A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
06/03/1999WO1999027089A1 A gene called xlis and the xlis gene product, called doublecortin and their preparations
06/03/1999WO1999027088A2 Novel gene and protein expressed in neural and pancreatic tissues
06/03/1999WO1999027087A1 Antisense oligonucleotides specific for cdk4
06/03/1999WO1999027086A1 Chimeric antisense oligonucleotides against tnf-alpha and their uses
06/03/1999WO1999027080A2 Human protein kinase and kinase inhibitors
06/03/1999WO1999027079A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999027078A1 Chemokine alpha-5
06/03/1999WO1999027077A1 Method for producing human intervertebral disc cells
06/03/1999WO1999027075A1 A carboxy-terminal brca1 interacting protein
06/03/1999WO1999027074A1 Novel tig
06/03/1999WO1999027073A1 deoD
06/03/1999WO1999026980A1 Methods and reagents for the utilization of sap family member proteins, novel signal transduction regulators
06/03/1999WO1999026979A1 Lactalbumin production process
06/03/1999WO1999026977A1 Novel receptors opg-2
06/03/1999WO1999026976A1 Tnf ligand family gene
06/03/1999WO1999026974A1 In vitro and in vivo growth-promoting proteins and peptides for kidney epithelial cells
06/03/1999WO1999026973A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026972A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026971A1 Antimicrobial peptides
06/03/1999WO1999026970A1 NOVEL pth
06/03/1999WO1999026969A1 Zoocin a immunity factor
06/03/1999WO1999026968A1 Oligopeptides and their use as antibacterial agents against staphylococcus strains
06/03/1999WO1999026967A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026965A1 Cyclosporine derivatives and uses thereof
06/03/1999WO1999026961A1 Secreted proteins and polynucleotides encoding them
06/03/1999WO1999026959A1 NOVEL recJ
06/03/1999WO1999026922A1 Substituted pyrrole derivatives as cell adhesion inhibitors
06/03/1999WO1999026663A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor
06/03/1999WO1999026660A2 Conjugates of cytokines and drugs or genes for treating proliferating cells
06/03/1999WO1999026658A1 Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
06/03/1999WO1999026656A1 Monoclonal human natural antibodies
06/03/1999WO1999026655A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor
06/03/1999WO1999026654A1 Vaccines with an ltb adjuvant
06/03/1999WO1999026652A1 Mucosal delivery system comprising lipophilic thrombin inhibitors
06/03/1999WO1999026651A1 ribH
06/03/1999WO1999026650A1 ribB
06/03/1999WO1999026649A1 Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
06/03/1999WO1999026648A1 Basic fibroblast growth factor treatment of sepsis
06/03/1999WO1999026647A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells
06/03/1999WO1999026646A1 ribA
06/03/1999WO1999026645A1 Method of mobilizing hematopoietic stem cells
06/03/1999WO1999026644A1 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
06/03/1999WO1999026634A1 Transcription factor decoy and tumor growth inhibitor
06/03/1999WO1999026630A1 Testosterone inhibitors and use for the protection of neurons
06/03/1999WO1999026623A1 Anti-obesity agent
06/03/1999WO1999026607A1 Drug delivery systems utilizing crystal structures
06/03/1999WO1999026595A1 Keratin-based hydrogel for biomedical applications and method of production
06/03/1999WO1999026570A1 Method of cross-linking keratin-based films, sheets, and bulk materials
06/03/1999WO1999026556A1 Biodegradable intra vaginal devices
06/03/1999WO1999026480A1 Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
06/03/1999WO1999026475A1 ribG
06/03/1999WO1999026463A2 Tnf ligand family gene
06/03/1999WO1999019488A9 Novel human egf receptors and use thereof
06/03/1999WO1999018996B1 Enterococcus antigens and vaccines
06/03/1999WO1999015656A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999014353A3 Intrabody-mediated control of immune reactions
06/03/1999WO1999014242A3 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/03/1999WO1999013894A3 Use of ifn-alpha and amantadine for the treatment of chronic hepatitis c
06/03/1999WO1999012965A3 April- a novel protein with growth effects
06/03/1999WO1999012576A3 Methods and compositions for treating cardiac and renal disorders with atrial natriuretic peptide and tissue kallikrein gene therapy
06/03/1999WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
1 ... 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 ... 3163